Meningococcus, a gram-negative diplococcus, is a leading cause of bacterial meningitis and septicemia, with potentially devastating consequences if not promptly diagnosed and treated. Neisseria meningitidis, the primary pathogen responsible for meningococcal disease, is classified into different serogroups based on the composition of its polysaccharide capsule. Serogroups A, B, C, W, X, and Y are the most clinically relevant, with variations in geographic distribution and epidemiological significance. Meningococcal infections typically present with symptoms such as fever, headache, stiff neck, and purpuric rash, necessitating urgent medical attention to prevent severe complications such as brain damage, organ failure, or death. Laboratory diagnosis of meningococcal disease relies on microbiological culture, molecular assays, and antigen detection tests to identify the presence of N. meningitidis in clinical specimens. Early recognition of meningococcal infection and prompt administration of appropriate antibiotics are crucial for improving patient outcomes and reducing the risk of transmission in close contacts.